Breaking News Instant updates and real-time market news.

AQST

Aquestive Therapeutics

$5.50

-0.3 (-5.17%)

19:03
05/07/19
05/07
19:03
05/07/19
19:03

Aquestive Therapeutics names Daniel Barber COO

Aquestive Therapeutics announced the appointment of Daniel Barber to the new position of Senior Vice President, Chief Operating Officer of Aquestive Therapeutics. Barber has worked at Aquestive since 2007, most recently in the role of Senior Vice President, Chief Strategy and Development Officer. In his expanded role as COO, Barber will also oversee end-to-end product operations, including product development, manufacturing, and quality assurance. Barber's new role is effective as of May 6, 2019.

  • 08

    May

AQST Aquestive Therapeutics
$5.50

-0.3 (-5.17%)

03/15/19
BMOC
03/15/19
NO CHANGE
Target $21
BMOC
Outperform
Aquestive Therapeutics price target lowered to $21 from $24 at BMO Capital
BMO Capital analyst Gary Nachman lowered his price target on Aquestive Therapeutics to $21 after its "in-line" Q4 results relative to its prior revenue pre-announcement. The analyst says investors may be concerned by the company's cash position in spite of the management's positive sentiment about the management's potential non-dilutive financing options. Nachman is keeping his Outperform rating on Aquestive Therapeutics however, stating that its guidance was "appropriately conservative" and should be "very achievable".
03/18/19
WEDB
03/18/19
NO CHANGE
Target $30
WEDB
Outperform
Aquestive Therapeutics recent selloff a buying opportunity, says Wedbush
Wedbush analyst Liana Moussatos notes that Aquestive Therapeutics ended 2018 with about $60.6M in cash and projects runway into Q1 of 2020 covering multiple clinical and regulatory catalysts in 2019. The analyst looks forward to the initiation of AQST-108/Anaphylaxis Phase 1 trial in Q2, Exservan/Amyotrophic Lateral Sclerosis NDA acceptance by the FDA, Libervant/Acute Repetitive/Refractory Seizures NDA submission in the second half of 2019 and AQST-119/Erectile Dysfunction NDA resubmission also in the second half of 2019. Overall, Moussatos believes management has consistently delivered on their proprietary pipeline and sees the recent selloff as a buying opportunity in front of multiple potential catalysts in 2019. She reiterates an Outperform rating and $30 price target on the shares.
04/22/19
HCWC
04/22/19
INITIATION
Target $10
HCWC
Buy
Aquestive Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Aquestive Therapeutics with a Buy rating and $10 price target. Aquestive is an emerging specialty pharma company optimizing the delivery of existing, well-known medications, says the analyst.
04/22/19
04/22/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zoom Video (ZM) initiated with a Sell at Summit Insights. 2. Agenus (AGEN) initiated with a Buy at B. Riley FBR. 3. Aquestive Therapeutics (AQST) initiated with a Buy at H.C. Wainwright. 4. Akamai (AKAM) initiated with a Buy at Needham. 5. Six Flags (SIX) initiated with a Hold at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FLWS

1-800-Flowers.com

$17.82

-0.18 (-1.00%)

08:50
05/24/19
05/24
08:50
05/24/19
08:50
Upgrade
1-800-Flowers.com rating change  »

1-800-Flowers.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 25

    Sep

08:50
05/24/19
05/24
08:50
05/24/19
08:50
General news
Treasury Action: yields dipped in the wake of the durables report »

Treasury Action: yields…

HIBB

Hibbett Sports

$19.84

-0.18 (-0.90%)

08:46
05/24/19
05/24
08:46
05/24/19
08:46
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

DVAX

Dynavax

$6.36

(0.00%)

08:46
05/24/19
05/24
08:46
05/24/19
08:46
Recommendations
Dynavax analyst commentary at RBC Capital »

Dynavax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

DFRG

Del Frisco's

$6.79

-0.1 (-1.45%)

, LABD

Daily S&P Biotech Bear 3x Shares

$23.31

0.66 (2.91%)

08:45
05/24/19
05/24
08:45
05/24/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

DFRG

Del Frisco's

$6.79

-0.1 (-1.45%)

LABD

Daily S&P Biotech Bear 3x Shares

$23.31

0.66 (2.91%)

FANG

Diamondback Energy

$103.78

-4.9 (-4.51%)

EWZ

MSCI Brazil Index

$39.10

-0.3 (-0.76%)

PEI

Pennsylvania REIT

$6.66

-0.04 (-0.60%)

WPG

Washington Prime

$4.47

0.015 (0.34%)

IWM

iShares Trust Russell 2000 Index Fund

$149.40

-3.17 (-2.08%)

BILI

Bilibili

$14.32

-0.37 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 04

    Jun

  • 06

    Jun

  • 06

    Jun

  • 26

    Jun

  • 13

    Nov

NPTN

NeoPhotonics

$3.88

-0.085 (-2.14%)

08:43
05/24/19
05/24
08:43
05/24/19
08:43
Recommendations
NeoPhotonics analyst commentary  »

NeoPhotonics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 04

    Jun

ZYME

Zymeworks

$17.65

0.02 (0.11%)

08:42
05/24/19
05/24
08:42
05/24/19
08:42
Conference/Events
Zymeworks to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SPLK

Splunk

$128.68

-7.12 (-5.24%)

08:41
05/24/19
05/24
08:41
05/24/19
08:41
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 09

    Jul

PDVW

pdvWireless

$44.25

1.25 (2.91%)

08:40
05/24/19
05/24
08:40
05/24/19
08:40
Recommendations
pdvWireless analyst commentary  »

pdvWireless price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 13

    Jun

08:40
05/24/19
05/24
08:40
05/24/19
08:40
General news
FX Action: The dollar »

FX Action: The dollar…

08:40
05/24/19
05/24
08:40
05/24/19
08:40
General news
U.S. durable goods orders fell 2.1% in April »

U.S. durable goods orders…

08:40
05/24/19
05/24
08:40
05/24/19
08:40
General news
U.S. equities are modestly firmer »

U.S. equities are…

BCRX

BioCryst

$3.54

0.09 (2.61%)

08:37
05/24/19
05/24
08:37
05/24/19
08:37
Downgrade
BioCryst rating change  »

BioCryst downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PLUS

ePlus

$72.62

-13.88 (-16.05%)

08:36
05/24/19
05/24
08:36
05/24/19
08:36
Hot Stocks
ePlus announces 500,000 share stock repurchase program »

ePlus announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASH

Ashland

$72.19

-0.435 (-0.60%)

08:35
05/24/19
05/24
08:35
05/24/19
08:35
Recommendations
Ashland analyst commentary  »

Ashland shares have 30%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLMN

Bloomin' Brands

$18.22

-1.98 (-9.80%)

08:33
05/24/19
05/24
08:33
05/24/19
08:33
Upgrade
Bloomin' Brands rating change  »

Guggenheim upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CETX

Cemtrex

$0.25

0.0158 (6.89%)

08:33
05/24/19
05/24
08:33
05/24/19
08:33
Hot Stocks
Cemtrex announces six-for-one reverse stock split to regain NASDAQ compliance »

Cemtrex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIBB

Hibbett Sports

$19.84

-0.18 (-0.90%)

08:31
05/24/19
05/24
08:31
05/24/19
08:31
Hot Stocks
Hibbett Sports appoints Anthony Crudele as independent chairman »

Hibbett Sports announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

BTU

Peabody Energy

$24.45

-0.855 (-3.38%)

08:30
05/24/19
05/24
08:30
05/24/19
08:30
Hot Stocks
Peabody Energy says proceeding with ventilation of North Goonyella Mine »

Peabody announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNR

China Metro-Rural

$5.70

-0.2 (-3.39%)

, LK

Luckin Coffee

$15.88

0.88 (5.87%)

08:30
05/24/19
05/24
08:30
05/24/19
08:30
Options
Five new option listings and four option delistings on May 24th »

New option listings for…

CNR

China Metro-Rural

$5.70

-0.2 (-3.39%)

LK

Luckin Coffee

$15.88

0.88 (5.87%)

ROAN

Roan Resources

$2.53

-0.32 (-11.23%)

EPE

EP Energy

$0.16

(0.00%)

FRSH

Papa Murphy's

$6.45

(0.00%)

NAVG

Navigators

$69.97

(0.00%)

NCS

NCI Building

$5.70

-0.2 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$165.84

-2.46 (-1.46%)

08:28
05/24/19
05/24
08:28
05/24/19
08:28
Recommendations
3M analyst commentary  »

3M likely to further…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

HIBB

Hibbett Sports

$19.84

-0.18 (-0.90%)

08:27
05/24/19
05/24
08:27
05/24/19
08:27
Hot Stocks
Hibbett Sports up 14.5% after Q1 results beat estimates, FY20 guidance raised »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

VALE

Vale

$11.78

0.03 (0.26%)

08:27
05/24/19
05/24
08:27
05/24/19
08:27
Upgrade
Vale rating change  »

Vale upgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$241.30

-6.22 (-2.51%)

08:24
05/24/19
05/24
08:24
05/24/19
08:24
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$147.97

-2.64 (-1.75%)

, TSS

TSYS

$99.61

-1.62 (-1.60%)

08:22
05/24/19
05/24
08:22
05/24/19
08:22
Recommendations
Global Payments, TSYS, ACI Worldwide, Bottomline Technologies, Jack Henry, USA Technologies, Q2 Holdings, Fiserv, First Data, FIS, Worldpay analyst commentary at Stephens »

Global Payments, TSYS…

GPN

Global Payments

$147.97

-2.64 (-1.75%)

TSS

TSYS

$99.61

-1.62 (-1.60%)

ACIW

ACI Worldwide

$31.61

-0.43 (-1.34%)

EPAY

Bottomline Technologies

$44.53

-0.53 (-1.18%)

JKHY

Jack Henry

$132.23

-3.43 (-2.53%)

USAT

USA Technologies

$7.22

0.05 (0.70%)

QTWO

Q2 Holdings

$72.44

-1.98 (-2.66%)

FISV

Fiserv

$87.23

-2.4 (-2.68%)

FDC

First Data

$25.88

-0.75 (-2.82%)

FIS

FIS

$120.45

-0.59 (-0.49%)

WP

Worldpay

$121.97

-0.48 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 05

    Jun

  • 11

    Jun

  • 11

    Jun

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.